Bioterrorism Week
Susan Hasty, Publisher
Table of Contents . . . November 7th, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Bioterrorism Week | Other Publications
Bioterrorism - Anthrax treatment study begins
Bioterrorism - Kentucky College of Pharmacy to develop treatments for people after radiation exposure
Biowarfare - Hapten that hydrolyzes nerve agent has been developed
Disaster Preparedness - Florida groups get $4.2 million grant from U.S. HRSA for disaster preparedness
Facilities - U.S. Centers for Disease Control and Prevention completes $165 million facility
Finance - $3.3M grant made to develop a smallpox vaccine
Research Funding - $20M U.S. NIH grant funds Proteome Systems' catalytic scavenger compounds
Vaccinia Virus - E3L inhibits apoptosis of host cells through Z-DNA binding
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
